Last reviewed · How we verify

NCT05458154

Evaluation and Re-evaluation of Post-mastectomy Pain Syndrome by Breast Cancer EDGE Task Force Outcomes

Completed NA Last updated 14 July 2022
What this trial tests

NA trial testing questionnaires in Post-mastectomy Pain Syndrome in 10 participants. Completed in 4 April 2022.

Timeline
3 March 2021
Primary endpoint
3 March 2022
4 April 2022

Quick facts

Lead sponsorGeneral Committee of Teaching Hospitals and Institutes, Egypt
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment10
Start date3 March 2021
Primary completion3 March 2022
Estimated completion4 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

General Committee of Teaching Hospitals and Institutes, Egypt

Who can join

Adults 18 to 70, female only, with Post-mastectomy Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the Breast Cancer EDGE Task Force is to provide physiotherapists with a comprehensive list of outcome measures that can be administered to a selected patient population, to assess post-mastectomy pain syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of questionnaires

Trials testing the same drug.

Other recruiting trials for Post-mastectomy Pain Syndrome

Currently open trials in the same condition.

Other General Committee of Teaching Hospitals and Institutes, Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05458154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing